The European Commission has taken a major step to introduce EU-wide controls on nine high-risk precursor chemicals used in illicit drug production via new legislation published this week. The Delegated Regulation (EU) 2026/314 (1) builds on the findings of the first EU-level precursor assessments carried out by the European Union Drugs Agency (EUDA) in 2025 (see news item).
Eight of the precursors in question are linked to the production of four synthetic cathinones (3-CMC, 3-MMC, 4-CMC, 4-MMC), while one substance (phenyl-2-nitropropene) is used in amphetamine production.
The regulation…
Read more
New substances, new markets, new risks — understanding Europe’s changing drug landscape starts with solid facts. On 9 June, the European Union Drugs Agency (EUDA) will launch the European Drug Report 2026: Trends and Developments in Brussels, delivering the latest evidence on the state of the drugs problem in Europe. Drawing on data from 29 countries (EU-27, Norway and Türkiye), the comprehensive analysis covers drug use and supply as well as drug-related harms and responses.
The online report features over 100 graphics, including interactive dashboards, allowing readers to visualise data…
Read more
The European Union Drugs Agency (EUDA) and the Ecuadorian Ministry of Foreign Affairs and Human Mobility have agreed a new joint work programme for 2026–2028, reinforcing their cooperation in addressing drug-related challenges at European and international level.
Signed by EUDA Executive Director Dr Lorraine Nolan and Ambassador Xavier Aliaga Sancho, Head of the Mission of Ecuador to the European Union, the programme builds on the Working Arrangement concluded on 3 July 2024. The work programme sets out practical cooperation activities aimed at strengthening data exchange, analytical…
Read more
